MD Medical Group annouces senior management and board of directors changes
|Download file (383 K)|
08 May 2019, Moscow - MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE:MDMG), a leading Russian private healthcare provider, today announces changes in its senior management team and Board of Directors.
Dr Alsu Nazyrova has stepped down as Director of Mother and Child Urals and as a member of the Board of Directors on May 07, 2019 to pursue other professional interests.
After joining the Company, Dr Alsu Nazyrova has been head of the Mother and Child clinic in Ufa, head of the Mother and Child hospital in Ufa – the Company’s first major medical centre opened in one of Russia’s regions. In 2016 she was appointed Director of Mother and Child Urals regional department, which incorporates several hospitals and clinics.
Dr Alsu Nazyrova became a member of the Board of Directors in June 2016.
Mark Kurtser, CEO of MDMG, said:
“Alsu Nazyrova has successively worked in the Company for many years, started her career as head of a clinic and became head of our Urals regional department. I want to thank Alsu Nazyrova greatly for her substantial contribution to the development of the Company and its regional network and would like to wish her success in her new professional activities”.
Svetlana Karimova, former deputy chief doctor at the Mother and Child hospital in Ufa, takes over as Head of the hospital, as well as Head of the Company’s clinics in Ufa, Perm and Kazan.
This announcement contains inside information.
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 4120
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 42 modern healthcare facilities, including 6 hospitals and 36 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, and Vladivostok.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012